 | • レポートコード：MRC2Q12-16721 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、抗ヒトカッパ軽鎖のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 抗ヒトカッパ軽鎖のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ヒトカッパ軽鎖の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ヒトカッパ軽鎖のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの抗ヒトカッパ軽鎖の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の抗ヒトカッパ軽鎖の売上および2028年までの予測に焦点を当てています。 抗ヒトカッパ軽鎖のグローバル主要企業には、Thermo Fisher Scientific、Abcam、Agilent、R&D Systems、BioLegend、Merck、Biocompare、Bio-Rad Antibodies、LSBio、Novus Biologicals、Fortis Life Sciences、RevMAbなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗ヒトカッパ軽鎖市場は、タイプとアプリケーションによって区分されます。世界の抗ヒトカッパ軽鎖市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 モノクローナル、ポリクローナル 【アプリケーション別セグメント】 ウエスタンブロット、免疫組織化学（IHC）、免疫細胞化学（ICC・IF）、ELISA、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗ヒトカッパ軽鎖製品概要 - タイプ別市場（モノクローナル、ポリクローナル） - アプリケーション別市場（ウエスタンブロット、免疫組織化学（IHC）、免疫細胞化学（ICC・IF）、ELISA、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の抗ヒトカッパ軽鎖販売量予測2017-2028 - 世界の抗ヒトカッパ軽鎖売上予測2017-2028 - 抗ヒトカッパ軽鎖の地域別販売量 - 抗ヒトカッパ軽鎖の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗ヒトカッパ軽鎖販売量 - 主要メーカー別抗ヒトカッパ軽鎖売上 - 主要メーカー別抗ヒトカッパ軽鎖価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（モノクローナル、ポリクローナル） - 抗ヒトカッパ軽鎖のタイプ別販売量 - 抗ヒトカッパ軽鎖のタイプ別売上 - 抗ヒトカッパ軽鎖のタイプ別価格 ・アプリケーション別市場規模（ウエスタンブロット、免疫組織化学（IHC）、免疫細胞化学（ICC・IF）、ELISA、その他） - 抗ヒトカッパ軽鎖のアプリケーション別販売量 - 抗ヒトカッパ軽鎖のアプリケーション別売上 - 抗ヒトカッパ軽鎖のアプリケーション別価格 ・北米市場 - 北米の抗ヒトカッパ軽鎖市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒトカッパ軽鎖市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗ヒトカッパ軽鎖市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒトカッパ軽鎖市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗ヒトカッパ軽鎖市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒトカッパ軽鎖市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗ヒトカッパ軽鎖市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒトカッパ軽鎖市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗ヒトカッパ軽鎖市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒトカッパ軽鎖市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Abcam、Agilent、R&D Systems、BioLegend、Merck、Biocompare、Bio-Rad Antibodies、LSBio、Novus Biologicals、Fortis Life Sciences、RevMAb ・産業チェーン及び販売チャネル分析 - 抗ヒトカッパ軽鎖の産業チェーン分析 - 抗ヒトカッパ軽鎖の原材料 - 抗ヒトカッパ軽鎖の生産プロセス - 抗ヒトカッパ軽鎖の販売及びマーケティング - 抗ヒトカッパ軽鎖の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗ヒトカッパ軽鎖の産業動向 - 抗ヒトカッパ軽鎖のマーケットドライバー - 抗ヒトカッパ軽鎖の課題 - 抗ヒトカッパ軽鎖の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Anti-human Kappa Light Chains estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Anti-human Kappa Light Chains is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Anti-human Kappa Light Chains is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Anti-human Kappa Light Chains is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Anti-human Kappa Light Chains include Thermo Fisher Scientific, Abcam, Agilent, R&D Systems, BioLegend, Merck, Biocompare, Bio-Rad Antibodies and LSBio, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Anti-human Kappa Light Chains companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Anti-human Kappa Light Chains market. Further, it explains the major drivers and regional dynamics of the global Anti-human Kappa Light Chains market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher Scientific
Abcam
Agilent
R&D Systems
BioLegend
Merck
Biocompare
Bio-Rad Antibodies
LSBio
Novus Biologicals
Fortis Life Sciences
RevMAb
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Anti-human Kappa Light Chains Segment by Type
Monoclonal
Polyclonal
Anti-human Kappa Light Chains Segment by Application
Western Blot
Immunohistochemistry (IHC)
Immunocytochemistry (ICC/IF)
ELISA
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Anti-human Kappa Light Chains market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Anti-human Kappa Light Chains market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Anti-human Kappa Light Chains, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-human Kappa Light Chains, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-human Kappa Light Chains revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Anti-human Kappa Light Chains market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Anti-human Kappa Light Chains revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Abcam, Agilent, R&D Systems, BioLegend, Merck, Biocompare, Bio-Rad Antibodies and LSBio, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anti-human Kappa Light Chains in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-human Kappa Light Chains companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-human Kappa Light Chains revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-human Kappa Light Chains Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global Anti-human Kappa Light Chains Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Western Blot
1.3.3 Immunohistochemistry (IHC)
1.3.4 Immunocytochemistry (ICC/IF)
1.3.5 ELISA
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-human Kappa Light Chains Market Perspective (2017-2028)
2.2 Anti-human Kappa Light Chains Growth Trends by Region
2.2.1 Anti-human Kappa Light Chains Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-human Kappa Light Chains Historic Market Size by Region (2017-2022)
2.2.3 Anti-human Kappa Light Chains Forecasted Market Size by Region (2023-2028)
2.3 Anti-human Kappa Light Chains Market Dynamics
2.3.1 Anti-human Kappa Light Chains Industry Trends
2.3.2 Anti-human Kappa Light Chains Market Drivers
2.3.3 Anti-human Kappa Light Chains Market Challenges
2.3.4 Anti-human Kappa Light Chains Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-human Kappa Light Chains Players by Revenue
3.1.1 Global Top Anti-human Kappa Light Chains Players by Revenue (2017-2022)
3.1.2 Global Anti-human Kappa Light Chains Revenue Market Share by Players (2017-2022)
3.2 Global Anti-human Kappa Light Chains Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-human Kappa Light Chains Revenue
3.4 Global Anti-human Kappa Light Chains Market Concentration Ratio
3.4.1 Global Anti-human Kappa Light Chains Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-human Kappa Light Chains Revenue in 2021
3.5 Anti-human Kappa Light Chains Key Players Head office and Area Served
3.6 Key Players Anti-human Kappa Light Chains Product Solution and Service
3.7 Date of Enter into Anti-human Kappa Light Chains Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-human Kappa Light Chains Breakdown Data by Type
4.1 Global Anti-human Kappa Light Chains Historic Market Size by Type (2017-2022)
4.2 Global Anti-human Kappa Light Chains Forecasted Market Size by Type (2023-2028)
5 Anti-human Kappa Light Chains Breakdown Data by Application
5.1 Global Anti-human Kappa Light Chains Historic Market Size by Application (2017-2022)
5.2 Global Anti-human Kappa Light Chains Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-human Kappa Light Chains Market Size (2017-2028)
6.2 North America Anti-human Kappa Light Chains Market Size by Type
6.2.1 North America Anti-human Kappa Light Chains Market Size by Type (2017-2022)
6.2.2 North America Anti-human Kappa Light Chains Market Size by Type (2023-2028)
6.2.3 North America Anti-human Kappa Light Chains Market Share by Type (2017-2028)
6.3 North America Anti-human Kappa Light Chains Market Size by Application
6.3.1 North America Anti-human Kappa Light Chains Market Size by Application (2017-2022)
6.3.2 North America Anti-human Kappa Light Chains Market Size by Application (2023-2028)
6.3.3 North America Anti-human Kappa Light Chains Market Share by Application (2017-2028)
6.4 North America Anti-human Kappa Light Chains Market Size by Country
6.4.1 North America Anti-human Kappa Light Chains Market Size by Country (2017-2022)
6.4.2 North America Anti-human Kappa Light Chains Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-human Kappa Light Chains Market Size (2017-2028)
7.2 Europe Anti-human Kappa Light Chains Market Size by Type
7.2.1 Europe Anti-human Kappa Light Chains Market Size by Type (2017-2022)
7.2.2 Europe Anti-human Kappa Light Chains Market Size by Type (2023-2028)
7.2.3 Europe Anti-human Kappa Light Chains Market Share by Type (2017-2028)
7.3 Europe Anti-human Kappa Light Chains Market Size by Application
7.3.1 Europe Anti-human Kappa Light Chains Market Size by Application (2017-2022)
7.3.2 Europe Anti-human Kappa Light Chains Market Size by Application (2023-2028)
7.3.3 Europe Anti-human Kappa Light Chains Market Share by Application (2017-2028)
7.4 Europe Anti-human Kappa Light Chains Market Size by Country
7.4.1 Europe Anti-human Kappa Light Chains Market Size by Country (2017-2022)
7.4.2 Europe Anti-human Kappa Light Chains Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-human Kappa Light Chains Market Size (2017-2028)
8.2 Asia-Pacific Anti-human Kappa Light Chains Market Size by Type
8.2.1 Asia-Pacific Anti-human Kappa Light Chains Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-human Kappa Light Chains Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-human Kappa Light Chains Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-human Kappa Light Chains Market Size by Application
8.3.1 Asia-Pacific Anti-human Kappa Light Chains Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-human Kappa Light Chains Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-human Kappa Light Chains Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-human Kappa Light Chains Market Size by Region
8.4.1 Asia-Pacific Anti-human Kappa Light Chains Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-human Kappa Light Chains Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-human Kappa Light Chains Market Size (2017-2028)
9.2 Latin America Anti-human Kappa Light Chains Market Size by Type
9.2.1 Latin America Anti-human Kappa Light Chains Market Size by Type (2017-2022)
9.2.2 Latin America Anti-human Kappa Light Chains Market Size by Type (2023-2028)
9.2.3 Latin America Anti-human Kappa Light Chains Market Share by Type (2017-2028)
9.3 Latin America Anti-human Kappa Light Chains Market Size by Application
9.3.1 Latin America Anti-human Kappa Light Chains Market Size by Application (2017-2022)
9.3.2 Latin America Anti-human Kappa Light Chains Market Size by Application (2023-2028)
9.3.3 Latin America Anti-human Kappa Light Chains Market Share by Application (2017-2028)
9.4 Latin America Anti-human Kappa Light Chains Market Size by Country
9.4.1 Latin America Anti-human Kappa Light Chains Market Size by Country (2017-2022)
9.4.2 Latin America Anti-human Kappa Light Chains Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-human Kappa Light Chains Market Size (2017-2028)
10.2 Middle East & Africa Anti-human Kappa Light Chains Market Size by Type
10.2.1 Middle East & Africa Anti-human Kappa Light Chains Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-human Kappa Light Chains Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-human Kappa Light Chains Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-human Kappa Light Chains Market Size by Application
10.3.1 Middle East & Africa Anti-human Kappa Light Chains Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-human Kappa Light Chains Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-human Kappa Light Chains Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-human Kappa Light Chains Market Size by Country
10.4.1 Middle East & Africa Anti-human Kappa Light Chains Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-human Kappa Light Chains Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Anti-human Kappa Light Chains Introduction
11.1.4 Thermo Fisher Scientific Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Anti-human Kappa Light Chains Introduction
11.2.4 Abcam Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.2.5 Abcam Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Anti-human Kappa Light Chains Introduction
11.3.4 Agilent Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.3.5 Agilent Recent Developments
11.4 R&D Systems
11.4.1 R&D Systems Company Details
11.4.2 R&D Systems Business Overview
11.4.3 R&D Systems Anti-human Kappa Light Chains Introduction
11.4.4 R&D Systems Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.4.5 R&D Systems Recent Developments
11.5 BioLegend
11.5.1 BioLegend Company Details
11.5.2 BioLegend Business Overview
11.5.3 BioLegend Anti-human Kappa Light Chains Introduction
11.5.4 BioLegend Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.5.5 BioLegend Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Anti-human Kappa Light Chains Introduction
11.6.4 Merck Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Biocompare
11.7.1 Biocompare Company Details
11.7.2 Biocompare Business Overview
11.7.3 Biocompare Anti-human Kappa Light Chains Introduction
11.7.4 Biocompare Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.7.5 Biocompare Recent Developments
11.8 Bio-Rad Antibodies
11.8.1 Bio-Rad Antibodies Company Details
11.8.2 Bio-Rad Antibodies Business Overview
11.8.3 Bio-Rad Antibodies Anti-human Kappa Light Chains Introduction
11.8.4 Bio-Rad Antibodies Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.8.5 Bio-Rad Antibodies Recent Developments
11.9 LSBio
11.9.1 LSBio Company Details
11.9.2 LSBio Business Overview
11.9.3 LSBio Anti-human Kappa Light Chains Introduction
11.9.4 LSBio Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.9.5 LSBio Recent Developments
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Details
11.10.2 Novus Biologicals Business Overview
11.10.3 Novus Biologicals Anti-human Kappa Light Chains Introduction
11.10.4 Novus Biologicals Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.10.5 Novus Biologicals Recent Developments
11.11 Fortis Life Sciences
11.11.1 Fortis Life Sciences Company Details
11.11.2 Fortis Life Sciences Business Overview
11.11.3 Fortis Life Sciences Anti-human Kappa Light Chains Introduction
11.11.4 Fortis Life Sciences Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.11.5 Fortis Life Sciences Recent Developments
11.12 RevMAb
11.12.1 RevMAb Company Details
11.12.2 RevMAb Business Overview
11.12.3 RevMAb Anti-human Kappa Light Chains Introduction
11.12.4 RevMAb Revenue in Anti-human Kappa Light Chains Business (2017-2022)
11.12.5 RevMAb Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer